Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
Vaccinia virus (VV) is a powerful tool for cancer treatment with the potential for tumor tropism, efficient cell-to-cell spread, rapid replication in cancer cells, and stimulation of anti-tumor immunity. It has a well-defined safety profile and is being assessed in late-stage clinical trials. Howeve...
Main Authors: | Claudia Hill, Megan Grundy, Luca Bau, Sheena Wallington, Joel Balkaran, Victor Ramos, Kerry Fisher, Len Seymour, Constantin Coussios, Robert Carlisle |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770521000449 |
Similar Items
-
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
by: Dobrin D. Draganov, et al.
Published: (2019-03-01) -
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs
by: Jérémy Béguin, et al.
Published: (2020-08-01) -
Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential
by: Pelin, Adrian
Published: (2019) -
Enhancing Oncolytic Virotherapy Using Functional Genomic Screening
by: Allan, Kristina Jean
Published: (2018) -
Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy
Published: (2020)